Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Assembly Biosciences (ASMB) Shares Outstanding (Weighted Average): 2015-2025

Historic Shares Outstanding (Weighted Average) for Assembly Biosciences (ASMB) over the last 11 years, with Sep 2025 value amounting to $7.7 million.

  • Assembly Biosciences' Shares Outstanding (Weighted Average) rose 20.91% to $7.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.7 million, marking a year-over-year increase of 20.91%. This contributed to the annual value of $6.4 million for FY2024, which is 16.08% up from last year.
  • Per Assembly Biosciences' latest filing, its Shares Outstanding (Weighted Average) stood at $7.7 million for Q3 2025, which was up 0.45% from $7.6 million recorded in Q2 2025.
  • In the past 5 years, Assembly Biosciences' Shares Outstanding (Weighted Average) registered a high of $7.7 million during Q3 2025, and its lowest value of $3.2 million during Q1 2021.
  • Over the past 3 years, Assembly Biosciences' median Shares Outstanding (Weighted Average) value was $6.3 million (recorded in 2024), while the average stood at $6.0 million.
  • Data for Assembly Biosciences' Shares Outstanding (Weighted Average) shows a peak YoY spiked of 46.10% (in 2024) over the last 5 years.
  • Over the past 5 years, Assembly Biosciences' Shares Outstanding (Weighted Average) (Quarterly) stood at $4.0 million in 2021, then increased by 1.92% to $4.1 million in 2022, then spiked by 34.71% to $5.5 million in 2023, then rose by 16.08% to $6.4 million in 2024, then climbed by 20.91% to $7.7 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $7.7 million for Q3 2025, versus $7.6 million for Q2 2025 and $7.5 million for Q1 2025.